Cargando…
Randomised trial evaluating chemotherapy alone or chemotherapy and a novel monoclonal antibody for canine T‐cell lymphoma: A multicentre US study
BACKGROUND: Canine peripheral nodal T‐cell lymphoma is considered chemotherapy resistant and carries a relatively poor prognosis. Prospective evaluations reporting the impact of chemotherapy on progression‐free survival (PFS) and overall survival time for dogs with T‐cell lymphoma are lacking. This...
Autores principales: | Musser, Margaret L., Clifford, Craig A., Bergman, Philip J., Treml, Laura S., McAnulty, Lydia C. Cook, McNiel, Elizabeth A., Johannes, Chad M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624070/ https://www.ncbi.nlm.nih.gov/pubmed/36329876 http://dx.doi.org/10.1002/vro2.49 |
Ejemplares similares
-
Pilot safety evaluation of doxorubicin chemotherapy combined with non-specific immunotherapy (Immunocidin®) for canine splenic hemangiosarcoma
por: Musser, Margaret L., et al.
Publicado: (2022) -
Safety evaluation of the canine osteosarcoma vaccine, live Listeria vector
por: Musser, Margaret L., et al.
Publicado: (2020) -
Diagnostic performance of the urinary canine calgranulins in dogs with lower urinary or urogenital tract carcinoma
por: Heilmann, Romy M., et al.
Publicado: (2017) -
Survey of airway management in intensive care units in the UK
por: Raobaikady, R, et al.
Publicado: (2003) -
Urine output in the first twelve hours after cardiopulmonary bypass does not predict the development of renal impairment
por: Ali, SM, et al.
Publicado: (1999)